Leonard James Good, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1077 Northern Blvd, Leonard J Good Md Po, Roslyn, NY 11576 Phone: 516-365-5500 Fax: 516-869-6946 |
Dr. Marie J Devezin, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 405 Elm Dr, Roslyn, NY 11576 Phone: 516-621-6579 |
Dr. Michael Mashaal, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 26 Sycamore Dr, Roslyn, NY 11576 Phone: 516-365-0621 |
News Archive
Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has received formal permission from the Drugs Controller General India (DCGI) to conduct a Phase II clinical trial of ADXS11-001, the Company's flagship drug construct, among 110 women with advanced, metastatic cervical cancer that has progressed subsequent to treatment with cytotoxic therapy. 55 women will receive ADXS11-001 alone, 55 will receive a combined regimen of both ADXS11-001 and cytotoxic therapy.
The Guardian reports on a "major summit" to be held in London on July 11, which "aims to provide access to family planning to 120 million women at an estimated cost of $4 billion." According to the newspaper, the summit "is being organized by the Bill & Melinda Gates Foundation and the British government's department for international development (DFID)," and "between 20 and 25 countries are scheduled to attend, including the U.S., India, Ethiopia, Nigeria and Tanzania."
Teva Pharmaceutical Industries Ltd. announced today the availability of new resources to support the recently introduced TjetĀ® injector system, a needle-free device designed to deliver Teva's TEV-TROPINĀ® [somatropin (rDNA origin) for injection] brand human growth hormone (hGH) to children who have growth failure due to inadequate secretion of normal endogenous growth hormone.
According to new statistics that would make Bob Vila cringe, the number of injuries from nail guns has almost doubled since 2001.
› Verified 9 days ago